skip to main content

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

News

Iron-sulfur minerals bear witness to earliest life on earth
15.05.2024 Iron-sulfur minerals bear witness to earliest life on earth Press Release
Direkt in der Nase: Antimikrobielles Peptid bekämpft pathogene Bakterien
08.05.2024 Direkt in der Nase: Antimikrobielles Peptid bekämpft pathogene Bakterien Press Release
Andreas Peschel in the ARD podcast "Medizin von morgen" with Eckart v. Hirschausen and Katharina Adick
23.04.2024 Andreas Peschel in the ARD podcast "Medizin von morgen" with Eckart v. Hirschausen and Katharina Adick In the Media

Events

PTMBact 2024: 5th International Conference on Post-Translational Modifications in Bacteria
29.05.2024 – 30.05.2024 PTMBact 2024: 5th International Conference on Post-Translational Modifications in Bacteria Conference Karl Forchhammer, Boris Macek More
From strings of nucleotides to collective behavior: “Lessons from Vibrio cholerae and its phages”
06.06.2024 From strings of nucleotides to collective behavior: “Lessons from Vibrio cholerae and its phages” 12:30 pm 2:00 pm Joint Microbiological Colloquium Kai Papenfort More
The effect of tRNA structure and codon context on translation efficiency and fidelity
13.06.2024 The effect of tRNA structure and codon context on translation efficiency and fidelity 12:30 pm 2:00 pm Joint Microbiological Colloquium Kelly T. Hughes More

About the CMFI

The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases it also damages the microbiome as a whole. 

 

CMFI researchers aim to develop new strategies to control microbial mechanisms and fight infections.

The Cluster of Excellence CMFI brings together researchers from different disciplines such as infection biology, immunology, bioinformatics, pharmaceutical biology, antibiotics research, molecular and medical microbiology, biotechnology, environmental biology, systems biology, chemistry, and medical history and ethics. Their common goal is to elucidate the mechanisms of interaction between beneficial and harmful bacteria and the host in order to develop novel targeted therapeutic and anti-infective treatments.

The CMFI is one of more than 50 Clusters of Excellence funded by German federal and state governments as part of the Excellence Initiative to sustainably strengthen Germany as a center of science, improve its international competitiveness and make cutting-edge research at German universities visible. In addition to the University of Tübingen, the Max Planck Institute for Biology and the University Hospital Tübingen are involved in the CMFI.

More about the Research